NanoPharmaceuticals is a clinical company developing targeted therapeutics for cancer, inflammatory disorders, angio-proliferative diseases
NanoPharmaceuticals has raised $623K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
NanoPharmaceuticals is headquartered in New York, United States.
NanoPharmaceuticals is a clinical company developing targeted therapeutics for cancer, inflammatory disorders, angio-proliferative diseases
NanoPharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NanoPharmaceuticals — Funding & Investors." VCBacked, February 4, 2025, https://www.vcbacked.co/company/nanopharmaceuticals. Accessed August 14, 2026.
VCBacked. (2025). NanoPharmaceuticals — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nanopharmaceuticals
{{cite web |title=NanoPharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/nanopharmaceuticals |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated